Our aim is to develop therapies to treat acquired brain injury and spinal cord injury
The Clem Jones Centre for Neurobiology and Stem Cell Research was established in 2016 at Griffith University. Based at the Griffith Institute for Drug Discovery, our laboratories are equipped to allow cutting-edge research ranging from high-throughput drug screening to complex three-dimensional assays.
The work of the Centre is made possible with funding from the Clem Jones Foundation and the Queensland Government. The Clem Jones Foundation is the philanthropic arm of the Clem Jones Group. The trustees are dedicated to benefiting the community through ongoing commitments to the wishes and philosophies of the late Dr Clem Jones AO.
News
Funding gift for spinal injury clinical trial
18 Nov 2024
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat...
World-first clinical trial for treating spinal cord injury
21 Oct 2024
A Phase I human clinical trial is set to commence to test the efficacy and safety of the...
$6.8 million grant for world-first Spinal Injury Project trial
12 Sep 2024
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord...
New views to restoring spinal function
11 Oct 2023
A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the...
Smell Clinic commences as researchers gather more data on Alzheimer’s disease
05 Sep 2023
A pilot smell clinic has commenced at Griffith’s Gold Coast campus in a bid to gather more data on...
Call for more research into what causes Alzheimer’s
27 Jul 2023
Calls for more study to be conducted into how microorganisms contribute to the onset and...
Funding boost for world-first cell transplantation research for nervous system...
30 Mar 2023
Griffith University’s world-first study into cell transplantation to repair injuries to the nervous...
Vale: Griffith farewells Alan Mackay-Sim, a titan of science
04 Jan 2023
Griffith University is paying tribute to one of its finest in Professor Emeritus Alan Mackay-Sim AM...
Griffith joins $280 million partnership to deliver mRNA vaccine outcomes
05 Dec 2022
Queensland will become a global mRNA vaccine hub with global healthcare company Sanofi partnering...
Griffith team start spinal cord injury rehabilitation trial
22 Nov 2022
Griffith University is seeking five people living with spinal cord injury to be part of stage two...
New research suggests nose picking could increase risk for Alzheimer’s and...
28 Oct 2022
Griffith University researchers have demonstrated that a bacteria can travel through the olfactory...
Bacteria in the nose may increase risk of Alzheimer’s disease
18 Feb 2022
A bacterium commonly present in the nose can sneak into the brain and may increase the risk of...
Paralysis treatment closer after donation funds Australian-first research trial
06 Nov 2020
An Australian-first rehabilitation trial considered the next crucial step in treating paralysis...
Griffith congratulates philanthropy award winners
08 Sep 2020
One of Griffith’s biggest supporters in the field of spinal cord injury research and a Griffith...
Videos
Virtual tour of our laboratory